These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9475892)

  • 1. Doxycycline and community-acquired pneumonia.
    Woolley RJ
    Am Fam Physician; 1998 Feb; 57(3):426-7. PubMed ID: 9475892
    [No Abstract]   [Full Text] [Related]  

  • 2. Community acquired pneumonia.
    Sargeant P
    Aust Fam Physician; 2004 Aug; 33(8):583; author reply 583. PubMed ID: 15373373
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxycycline for community-acquired pneumonia.
    Cunha BA
    Clin Infect Dis; 2003 Sep; 37(6):870. PubMed ID: 12955665
    [No Abstract]   [Full Text] [Related]  

  • 4. Doxycycline for nursing home acquired pneumonia (NHAP).
    Cunha BA
    Scand J Infect Dis; 2009; 41(1):77-8, author reply 76. PubMed ID: 18821134
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment for community acquired pneumonia: more support for doxycycline.
    Ditmanson L; Apgar D
    Arch Intern Med; 1999 Aug 9-23; 159(15):1814-5. PubMed ID: 10448791
    [No Abstract]   [Full Text] [Related]  

  • 6. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002).
    Jones RN; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):147-9. PubMed ID: 15183865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.
    Gilbert DN
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S121-2. PubMed ID: 18986276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Community acquired pneumonia: how to proceed when the antibiotic does not help?].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Sep; 153(38):12, 14. PubMed ID: 21977789
    [No Abstract]   [Full Text] [Related]  

  • 9. Community-acquired pneumonia.
    Luh JY; Karnath BM
    N Engl J Med; 2003 Apr; 348(14):1408-9; author reply 1408-9. PubMed ID: 12672875
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention and treatment recommendations for community acquired pneumonia.
    Gifford DS
    Med Health R I; 2002 Jan; 85(1):30-1. PubMed ID: 11824153
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of community-acquired pneumonia].
    Dorca J; Fernández S
    Arch Bronconeumol; 1998 Nov; 34 Suppl 2():50-6. PubMed ID: 9846213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is short-course treatment an option for community-acquired pneumonia?].
    Petitpretz P
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S106-7. PubMed ID: 18598857
    [No Abstract]   [Full Text] [Related]  

  • 13. How much evidence do we have to recommend oral doxycycline for empirical treatment of community-acquired pneumonia?
    Bantar C
    Clin Infect Dis; 2004 Feb; 38(3):459-60. PubMed ID: 14727226
    [No Abstract]   [Full Text] [Related]  

  • 14. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia also applicable in The Netherlands].
    Peetermans WE; Verhaegen J
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2200-1; author reply 2201-2. PubMed ID: 9550807
    [No Abstract]   [Full Text] [Related]  

  • 16. [Short course antibiotherapies in community-acquired pneumonia].
    Bulbul Y; Ozlu T
    Tuberk Toraks; 2008; 56(3):344-52. PubMed ID: 18932039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of antimicrobial resistance in community-acquired pulmonary pathogens.
    Cunha BA; Shea KW
    Semin Respir Infect; 1998 Mar; 13(1):43-53. PubMed ID: 9543475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia.
    Bradford PA; Petersen PJ; Tuckman M; Jones CH
    Clin Microbiol Infect; 2008 Sep; 14(9):882-6. PubMed ID: 18844692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of community-acquired pneumonia].
    Fernández de la Puebla Giménez RA
    Med Clin (Barc); 2003 Jun; 121(1):36. PubMed ID: 12812708
    [No Abstract]   [Full Text] [Related]  

  • 20. 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
    Roig J; Casal J; Gispert P; Gea E
    Med Mal Infect; 2006; 36(11-12):680-9. PubMed ID: 17095177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.